Literature DB >> 15736358

Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis.

G H Tomkin1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 15736358     DOI： 10.1007/bf03170507

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  38 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

3.  Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

4.  Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.

Authors:  M E Griffin; D McInerney; A Fraser; A H Johnson; P B Collins; D Owens; G H Tomkin
Journal:  Diabet Med       Date:  1997-09       Impact factor: 4.359

5.  The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus.

Authors:  S P Laing; A J Swerdlow; S D Slater; J L Botha; A C Burden; N R Waugh; A W Smith; R D Hill; P J Bingley; C C Patterson; Z Qiao; H Keen
Journal:  Diabet Med       Date:  1999-06       Impact factor: 4.359

6.  Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.

Authors:  K Malmberg; A Norhammar; H Wedel; L Rydén
Journal:  Circulation       Date:  1999-05-25       Impact factor: 29.690

7.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

8.  Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

Authors:  A Bowie; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Atherosclerosis       Date:  1993-08       Impact factor: 5.162

9.  Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus.

Authors:  A S Krolewski; E J Kosinski; J H Warram; O S Leland; E J Busick; A C Asmal; L I Rand; A R Christlieb; R F Bradley; C R Kahn
Journal:  Am J Cardiol       Date:  1987-04-01       Impact factor: 2.778

10.  Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.

Authors:  S H Gianturco; M P Ramprasad; R Song; R Li; M L Brown; W A Bradley
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-06       Impact factor: 8.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.